ROIV
Roivant Sciences Ltd. · Healthcare
President and CIO Mayukh Sukhatme sold $9.0M of Roivant Sciences Ltd.
Sold$8,985,003
$26.47Price
339,441Shares
−2%Stake
What ROIV did after the filing
- The stock from Wed, Feb 11 close, $26.80
- +2.1%
- S&P 500, same days
- −6.8%
Measured over 30 trading days, to the Mar 26 close.
Traded Mon, Feb 9. Filed Wed, Feb 11, 12:53 PM ET, during the session. Returns use the Feb 11 close and the Mar 26 close. Not investment advice.